ClinVar Miner

Submissions for variant NC_000011.9:g.(?_108163326)_(108170632_?)del

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV004580065 SCV005062573 likely pathogenic Ataxia-telangiectasia syndrome 2023-05-12 criteria provided, single submitter clinical testing In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts a region of the ATM protein in which other variant(s) (p.Leu1715Pro) have been observed in individuals with ATM-related conditions (PMID: 26896183, 30819809). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant is also known as deletion of exons 32-36. A similar copy number variant has been observed in individual(s) with ataxia-telangiectasia (PMID: 16941484). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is a gross deletion of the genomic region encompassing exon(s) 30-34 of the ATM gene. This variant would be expected to be in-frame, preserving the integrity of the reading frame.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.